Back
Top 1%
19.2%
Top 0.3%
12.8%
Top 18%
10.1%
Top 0.6%
8.4%
Top 2%
7.0%
Top 0.1%
7.0%
Top 1%
4.2%
Top 18%
2.3%
Top 35%
2.1%
Top 2%
2.1%
Top 4%
2.1%
Top 1.0%
2.1%
Top 91%
2.1%
Top 13%
1.4%
Top 4%
1.4%
Top 61%
1.0%
Top 32%
0.8%
Top 3%
0.8%
Top 21%
0.8%
Top 10%
0.8%
Impact of 18FDG-avidity and immunosuppression on idiopathic and genetic cardiomyopathies
2026-02-03
cardiovascular medicine
Title + abstract only
View on medRxiv
Show abstract
BackgroundMyocardial 18fluorodeoxyglucose (18FDG)-avidity is frequently seen in patients with genetic cardiomyopathy (CMP), as well as a growing "idiopathic 18FDG-avidity" group of genotype-negative patients who do not clearly have cardiac sarcoidosis (CS). ObjectivesTo determine the prognostic implications of 18FDG-avidity in patients with and without genetic CMP, and the effects of immunosuppression in the latter. MethodsThis multicenter, retrospective study included all patients who were re...
Predicted journal destinations
1
Journal of the American Heart Association
92 training papers
2
Circulation
37 training papers
3
Scientific Reports
701 training papers
4
Circulation: Genomic and Precision Medicine
30 training papers
5
Frontiers in Cardiovascular Medicine
33 training papers
6
The American Journal of Cardiology
15 training papers
7
Heart Rhythm
16 training papers
8
eLife
262 training papers
9
Nature Communications
483 training papers
10
European Heart Journal - Digital Health
15 training papers
11
Open Heart
18 training papers
12
Atherosclerosis
16 training papers
13
PLOS ONE
1737 training papers
14
Journal of Clinical Medicine
77 training papers
15
Hypertension
20 training papers
16
BMJ Open
553 training papers
17
BMC Medicine
155 training papers
18
Frontiers in Physiology
18 training papers
19
PLOS Medicine
95 training papers
20
Nature Genetics
72 training papers